Jessica Walradt, MS, BA


Policy Solutions to Facilitate the New eCQM ACO Reporting and Advancement of Interoperability

This article describes the challenges associated with aggregating and reporting quality data via electronic health records and discusses corresponding policy solutions.

Emma K. Harrington, PhD


Discharge Prescribing and Subsequent Opioid Use After Traumatic Musculoskeletal Injury

The authors use surgical resident assignment as an instrumental variable for discharge opioid prescribing and estimate the impact of discharge opioid supply on subsequent use.

Neil Wagle, MD, MBA


A Clinical Pathway to Well-Being: Putting Patient Priorities at the Center of Care

Using patient priorities and converting them into treatment goals result in better primary care outcomes for Medicare patients.

Leah L. Zullig, PhD, MPH


Association Between Low-Income Subsidies and Inequities in Orally Administered Antimyeloma Therapy Use

Medicare Part D low-income subsidies alone are insufficient to improve the uptake and equitable use of high-cost, orally administered antimyeloma therapy.

Jafar Dada, MD


Mortality Risk Stratification Can Predict Readmissions but Not Length of Stay

Mortality risk stratification can identify patients at higher risk of mortality and readmissions for prevention strategies. Other patients should be the focus of length-of-stay reduction strategies.

Jeremy W. Bray, PhD


Association of Opioid Utilization Management With Prescribing and Overdose

Opioid utilization management in Medicare was associated with mixed effects on opioid prescribing, and prior authorization was associated with a decreased likelihood of subsequent overdose.

Christina Larson Chebili, MA


Chemotherapy-Induced Peripheral Neuropathy in Metastatic Breast Cancer Patients Initiating Intravenous Paclitaxel/nab-Paclitaxel

We examine the incidence and impact of chemotherapy induced peripheral neuropathy on clinical and economic outcomes in women with metastatic breast cancer initiating intravenous paclitaxel/nab-paclitaxel.

Leslie Chang Evertson, DNP, RN, GNP-BC


Chronic Disease Management: Why Dementia Care Is Different

Because of its often slowly progressive nature, dementia is often included among chronic disease management programs. Yet, for many reasons, its management demands different approaches.

Jeffrey Turner, MD


Future of Cardiorenal Metabolic Syndrome Management

Jeffrey Turner, MD; Nihar R. Desai, MD, MPH; and Om P. Ganda, MD, provide closing thoughts on the future of cardiorenal metabolic syndrome management.

Tsan-Yao Huang, PhD


Clinic Price Reductions in a Tiered Total Cost Benefit Design

Findings of this evaluation of primary care clinic responses in a tiered total cost of care benefit design suggest that clinics respond by reducing prices.

Daniel Muñoz, MD, MPA


Association of Physician Coordination With Interfacility Transfer Acceptance Timeliness

The authors reviewed physician-to-physician conversations during emergency transfer of patients with ST-segment elevation myocardial infarction and found that higher-quality physician coordination was associated with faster time to acceptance.

Shonda Vink, MPH


Relationships Between Patient Portal Activation and Patient Satisfaction Scores Among CG-CAHPS and HCAHPS Respondents

Patients with activated patient portal accounts report higher patient satisfaction in respective dimensions of the Clinician and Group Consumer Assessment of Healthcare Providers and Systems (CG-CAHPS) and Hospital CAHPS (HCAHPS) surveys compared with patients without portal accounts.

Kimberly Lenz, PharmD


Evaluating Proactive Outreach for Prior Authorization Recertifications in Medicaid Patients

Implementing a proactive provider outreach program resulted in significantly more prior authorization recertifications and a reduction in time to submission.

John Mark Kelton, PharmD


Real-world Usage of Bevacizumab-bvzr Biosimilar in US Oncology Practice

Real-world adoption of bevacizumab-bvzr biosimilar was retrospectively assessed, revealing switching between biosimilars and the reference product and utilization in extrapolated indications and combination regimens.

Tashi Chodon, MPH, BSN


Community Health Workers’ Critical Role in Trust Building Between the Medical System and Communities of Color

The authors interrogate elements of routine medical practice in New York City to argue for reforms of hospital culture through relational trust-building capabilities of community health workers.

Phil Sarocco, RPh, MSc


Adverse Drug Effects Across Patients With Heart Failure: A Systematic Review

This systematic literature review reports incidence of adverse drug effects associated with guideline-directed medical therapy for patients with heart failure with reduced ejection fraction.

Jason Ouyang, MD, MPH


Association of Co-pay Elimination With Medication Adherence and Total Cost

This study evaluated cost and utilization attributed to members enrolled in a health care program with no pharmacy co-pay. Health care savings were identified in addition to medication adherence improvements.

Todd L. Foster, PhD


An Outpatient Critical Care Transition Clinic Model Reduces Admissions/Readmissions in Medically Complex Patients

Critical care transition clinic patients with chronic conditions had a 31% reduction in relative risk for inpatient admissions, and the clinic reduced cost by more than $1 million.

Perry N. Halkitis, PhD, MS, MPH | Image Credit: Rutgers School of Public Health
Perry N. Halkitis, PhD, MS, MPH


Contributor: A Crisis in Public Health—Addressing the Exodus From Our Essential Workforce

Public health professionals are the backbone of our health system, and their contributions are vital to the well-being of our communities. As a society, we must value their work, provide the support they need, and ensure that public health remains a rewarding and viable career choice.

Paula Bickley


Bridging the Gap Between Medical and Pharmacy Benefits

As health care costs rise, especially for patients with complex conditions, a major barrier to access is the disconnect between medical benefits and pharmacy benefits.

Suzanne W. Dixon, MPH, MS, RDN


Transition-to-Dialysis Planning, Health Care Use, and Mortality in End-Stage Renal Disease

A planned transition to dialysis was associated with improved outcomes and lower mortality. These findings may inform care coordination policies for end-stage renal disease.

Lori Timmins, PhD


Primary Care Redesign and Care Fragmentation Among Medicare Beneficiaries

This article examines the association between a large-scale primary care redesign—the Comprehensive Primary Care Plus Initiative—and ambulatory care patterns of Medicare beneficiaries with highly fragmented care.

Amy D. Herschell, PhD


Increased Likelihood of Psychiatric Readmission With Medicaid Expansion vs Legacy Coverage

Individuals who became eligible for Medicaid through Medicaid expansion have an increased likelihood of psychiatric readmission compared with their legacy-enrolled counterparts.

Erin Hunter


Smoking Cessation Associated With Increased Survival Among Patients With Lung Cancer

Former and current smokers showed higher mortality from early-stage non-small cell lung cancer than never smokers.

Derek DeLia, PhD


Primary Care for New vs Established Medicaid Enrollees

Under Affordable Care Act Medicaid expansion in New Jersey, new and distinct patterns of primary care utilization emerged for new vs established enrollees.

Patrick Racsa, MS


Value-Based Care Through Postacute Home Health Under CMS PACT Regulations

Among a patient population defined by CMS postacute care transfer regulations, home health vs no postacute care was associated with reduced 30-day readmissions and costs.

Jeffrey Walter, BA


Implementing Multistate Behavioral Health Pay-for-Performance Initiatives in Medicaid Managed Care

The authors describe a pay-for-performance initiative targeting behavioral health providers, which was introduced by a large Medicaid managed care organization across multiple states.

Micaela Laber, MPH, MBA


Humira: The First $20 Billion Drug

The authors review a House Oversight Committee investigation report on AbbVie’s practices pertaining to adalimumab (Humira) to shed light on broader pharmaceutical market dynamics hindering a competitive market.

© 2023 MJH Life Sciences
All rights reserved.